1. 1
Craig A. Goodman Ph.D.
Agnes-Pockels-Bogen 1
80992 Munich
Education
INSTITUTION DEGREE YEAR FIELD OF STUDY
Technion – Israel Institute of
Technology, Bruce Rappaport
Faculty of Medicine
Post-
Doctorate
2005 Neurocognition
Hebrew University of Jerusalem,
Hadassah Medical School
Ph.D. 2004 Neurobiology
California State University,
Northridge
MA 1998 Clinical Psychology
San Francisco State University BA 1993 Psychology
Positions and Experience
7/2015-Present Clinician – CR/CREV, MedAvante, GmbH, Munich, Germany
 Evaluate a wide range of patients using various symptom rating scales
Blindly review, score, and provide feedback to site raters regarding
standardized structured and semi-structured diagnostic and severity
assessments, including (but not limited to) Alzheimer’s Disease Assessment
Scale – Cognitive Subscale (ADAS-Cog), Alzheimer’s Disease Cooperative
Study Activities of Daily Living (ADCS-ADL), Beck Anxiety Inventory (BAI),
Brief Psychiatric Rating Scale (BPRS), Clinical Dementia Rating Scale (CDRS),
Clinical Global Impressions Scale (CGI), Disability Assessment for
Dementia (DAD), Global Deterioration Scale (GDS), Hamilton Anxiety Rating
Scale (HAM-A), Hamilton Depression Rating Scales (HAM-D), Mini-Mental
State Examination (MMSE), Movement Disorder Society - Unified Parkinson's
Disease Rating Scale (MDS-UPDRS), Columbia-Suicide Severity Rating
Scale (C-SSRS).
1/2015-1/2016 Senior Lecturer, Ruppin Academic Center, The School of
Social and Community Sciences, M.A. Program in Clinical Geropsychology,

2. 2
Emek Hefer, Israel
 Teach neurocognitive testing and Cognitive Behavioral Therapy
 Provides clinical supervision to Master’s level clinicians in the College
Psychology Department
 Supervises Master’s level student practicums and research
2007-2008 Adjunct Lecturer, Tel Aviv-Yaffo Academic College, Tel Aviv, Israel
 Lecturer in Faculty of Social Studies.
 Taught psychology undergraduate courses, including Multicultural
Counseling, Counseling Techniques and Psychopathology
2002-Present Head Psychologist/Researcher/Lecturer, Lev Hasharon Mental
Health Center, Psycho-Geriatric Ward and Holocaust
Survivors Residence, Pardesiyah, Israel
 Conduct diagnostic evaluations and individual and group cognitive and
psychotherapy in an inpatient psychiatric hospital unit with adult, and
geriatric patients presenting with acute and chronic moderate to severe
mental health disorders: Mood, Psychotic, Substance Use, Personality, and
Dementia
 Administered standardized semi-structured and structured instruments, and
severity assessments, to patients and such instruments included (but were
not limited to) the Structured Clinical Interview for DSM-IV Disorders Axis I
(SCID) including (but not limited to) the Addenbrooke’s Cognitive
Examination (ACE) , Alzheimer’s Disease Assessment Scale – Cognitive
Subscale (ADAS-Cog), Alzheimer’s Disease Cooperative Study Activities of
Daily Living (ADCS-ADL), Beck Anxiety Inventory (BAI), Brief Psychiatric
Rating Scale (BPRS), Clinical Dementia Rating Scale (CDRS), Clinical Global
Impressions Scale (CGI), Disability Assessment for
Dementia (DAD), Global Deterioration Scale (GDS), Hamilton Anxiety Rating
Scale (HAM-A), Hamilton Depression Rating Scales (HAM-D), Mini-Mental
State Examination (MMSE), Minnesota Multiphasic Personality Inventory-2
(MMPI-2), Negative Symptom Assessment (NSA), Personality Assessment
Inventory (PAI), Positive and Negative Syndrome Scale (PANSS), Rey
Auditory verbal Learning Test (RAVLT), Rey Osterrieth Complex Figure
(ROCF), Rorschach Inkblot Test, Scale for the Assessment of Positive
Symptoms (SAPS), Severe Impairment Battery (SIB), Structured Clinical
Interview for DSM-IV Disorders Axis I (SCID-I), Thematic Apperception Test
(TAT), Trail Making A and B, Wechsler Adult Intelligence Scale (WAIS),
Wechsler Intelligence Scale for Children (WISC), Wechsler Memory Scale
(WMS), Wisconsin Card Sorting Test (WCST).
 Evaluated cognitive, functional, and behavioral symptoms with geriatric
patients and their caregivers to determine overall global status of impairment
as well as progression on follow up assessments
 Lecturer for medical students and resident psychiatrists and psychologists.
 Conduct neurocognitive and neuropsychological research.

3. 3
 Evaluate a wide range of patients using various symptom rating scales, score,
standardized structured and semi-structured diagnostic scales.
2002- Present Adjunct Lecturer, Sackler Medical School, Tel Aviv University, Ramat
Aviv, Israel
 Lecturer of psychiatry, neuropsychology and neurocognition for medical
students (in English and Hebrew) psychiatry residents, and continuing
education for certified psychiatrists.
9/2002-9/2005 Researcher, Sha’ar Manashe Mental Health Center, Brain
Behavior Laboratory, Mobile Post Hefer 38814, Israel
 Conducted diagnostic evaluations and psychopharmacology treatment at an
inpatient psychiatric hospital unit with adult patients presenting with
moderate to severe acute and chronic mental health disorders: Mood,
Psychotic, and Substance Use Disorders
 As the Principal Investigator (or Co-Investigator) of clinical drug trials
(Phases III and IV), conducted diagnostic evaluations at an outpatient clinical
trial setting with adult, and geriatric subjects presenting with chronic
moderate to severe mental health disorders: Mood Disorders, Psychotic
Disorders, Dementia, and Substance Use Disorders
 Conducted diagnostic evaluations and individual and group cognitive and
psychotherapy in an inpatient psychiatric hospital unit with adult, and
geriatric patients presenting with acute and chronic moderate to severe
mental health disorders: Mood, Psychotic, Substance Use, Personality, and
Dementia.
 Administered standardized semi-structured and structured instruments, and
severity assessments, to patients and such instruments included (but were
not limited to) the Structured Clinical Interview for DSM-IV Disorders Axis I
(SCID) including (but not limited to) the Addenbrooke’s Cognitive
Examination (ACE) , Alzheimer’s Disease Assessment Scale – Cognitive
Subscale (ADAS-Cog), Alzheimer’s Disease Cooperative Study Activities of
Daily Living (ADCS-ADL), Beck Anxiety Inventory (BAI), Brief Psychiatric
Rating Scale (BPRS), Clinical Dementia Rating Scale (CDRS), Clinical Global
Impressions Scale (CGI), Disability Assessment for
Dementia (DAD), Global Deterioration Scale (GDS), Hamilton Anxiety Rating
Scale (HAM-A), Hamilton Depression Rating Scales (HAM-D), Mini-Mental
State Examination (MMSE), Minnesota Multiphasic Personality Inventory-2
(MMPI-2), Negative Symptom Assessment (NSA), Personality Assessment
Inventory (PAI), Positive and Negative Syndrome Scale (PANSS), Rey
Auditory verbal Learning Test (RAVLT), Rey Osterrieth Complex Figure
(ROCF), Rorschach Inkblot Test, Scale for the Assessment of Positive
Symptoms (SAPS), Severe Impairment Battery (SIB), Structured Clinical
Interview for DSM-IV Disorders Axis I (SCID-I), Thematic Apperception Test
(TAT), Trail Making A and B, Wechsler Adult Intelligence Scale (WAIS),
Wechsler Intelligence Scale for Children (WISC), Wechsler Memory Scale
(WMS), Wisconsin Card Sorting Test (WCST).

4. 4
 Evaluated cognitive, functional, and behavioral symptoms with geriatric
patients and their caregivers to determine overall global status of impairment
as well as progression on follow up assessments
 Evaluated a wide range of patients using various symptom rating scales,
score, standardized structured and semi-structured diagnostic scales.
 Evaluated cognitive, functional, and behavioral symptoms with geriatric and
psychotic patients to determine overall global status of impairment as well as
cognitive impairment.
 Lecturer for medical students and resident psychiatrists and psychologists.
 Conducted neurocognitive and neuropsychological research.
9/2002-9/2005 Postdoctoral Fellowship, Technion – Israel Institute of Technology
Bruce Rappaport Faculty of Medicine, Haifa, Israel
 Conducted diagnostic evaluations and psychopharmacology treatment at an
inpatient psychiatric hospital unit with adult patients presenting with
moderate to severe acute and chronic mental health disorders: Mood,
Psychotic, and Substance Use Disorders
 As the Principal Investigator (or Co-Investigator) of clinical drug trials
(Phases III and IV), conducted diagnostic evaluations at an outpatient clinical
trial setting with adult, and geriatric subjects presenting with chronic
moderate to severe mental health disorders: Mood Disorders, Psychotic
Disorders, Dementia, and Substance Use Disorders
 Administered standardized semi-structured and structured instruments to
patients and such instruments included (but were not limited to) the
Structured Clinical Interview for DSM-IV Disorders Axis I (SCID), Wechsler
Adult Intelligence Scale (WAIS), Wechsler Memory Scale (WMS), and the Mini
Mental State Examination
 Evaluated cognitive, functional, and behavioral symptoms with geriatric and
psychotic patients to determine overall global status of impairment as well as
cognitive impairment.
 Lecturer for medical students and resident psychiatrists and psychologists.
 Conducted neurocognitive and neuropsychological research.
9/1998-6/2002 Researcher, Hebrew University of Jerusalem, Hadassah Medical
School, Physiology Department, Jerusalem, Israel
 Researcher in a physiology laboratory conducted Electroencephalography (EEG)
and evoked potential research related to aging and schizophrenia, utilizing
Neuroscan EEG systems.
9/2000-9/2002 Researcher, Kfar Shaul Mental Hospital, Neurophysiology Laboratory,
Jerusalem, Israel
 Researcher in a physiology laboratory conducted EEG and evoked potential
research related to aging and schizophrenia, utilizing Neuroscan EEG
systems.

5. 5
9/1995-8/1998 Researcher, California State University Northridge, Psychology
Department. Northridge, California, U.S.A.
 Head of Neuropsychology Laboratory, conducted EEG and evoked potential
research related to aging, utilizing Neuroscan EEG systems.
 Administrative Director of the Mandatory Continuing
Education for Psychologists and Psychiatrists in Conjunction with the
California Psychological Association. Logistics Coordinator, Academic Advisor
and Assistant Head of the Academic Advisement Center.
1995-1998 Internship, University of Los Angeles (U.C.L.A.) Neuropsychiatric
Institute (NPI). Los Angeles, California, U.S.A.
 Trained and worked in Neurophysiology laboratory, conducted
neurophysiological and neuropsychological research.
8/1994-6/1995 Internship, San Francisco State University, Psychology Department.
San Francisco, California, U.S.A.
 Trained and worked in the Biofeedback Research Laboratory designing and
carrying out research on relaxation using biofeedback instrumentation, and
data acquisition.
 Utilized Lab View Computer Research Program to help develop software.
10/1994-2/1995 Internship, St. Mary's Hospital, McAuley Neuropsychiatric Adolescent
Impatient Program. San Francisco, California, U.S.A.
 Conducted diagnostic evaluations and individual psychotherapy at an
inpatient and residential community mental health center with teenagers
presenting with acute and persistent moderate to severe mental disorders:
Mood, Psychotic, Dementia, Substance Use, Anxiety and Personality
Disorders
Scale Administration Experience
INSTRUMENT
Addenbrooke’s Cognitive Examination (ACE)
Alzheimer’s Disease Assessment Scale
Alzheimer’s Disease Cooperative Study Activities of Daily Living (ADCS-ADL)
Beck Anxiety Inventory (BAI)
Brief Psychiatric Rating Scale (BPRS)
Clinical Dementia Rating Scale (CDRS)
Clinical Global Impressions Scale (CGI)
Cognitive Subscale (ADAS-Cog)
Disability Assessment for Dementia (DAD)

6. 6
Global Deterioration Scale (GDS)
Hamilton Anxiety Rating Scale (HAM-A)
Hamilton Depression Rating Scales (HAM-D)
Mini-Mental State Examination (MMSE)
Minnesota Multiphasic Personality Inventory-2 (MMPI-2)
Negative Symptom Assessment (NSA)
Personality Assessment Inventory (PAI)
Positive and Negative Syndrome Scale (PANSS)
Rey Auditory verbal Learning Test (RAVLT)
Rey Osterrieth Complex Figure (ROCF)
Rorschach Inkblot Test
Scale for the Assessment of Positive Symptoms (SAPS)
Severe Impairment Battery (SIB)
Structured Clinical Interview for DSM-IV Disorders Axis I (SCID-I)
Thematic Apperception Test (TAT)
Trail Making A and B
Wechsler Adult Intelligence Scale (WAIS)
Wechsler Intelligence Scale for Children (WISC)
Wechsler Memory Scale (WMS)
Wisconsin Card Sorting Test (WCST)
Publications
Lerner, A.G., Goodman, C., Rudinski, D., & Lev Ran, S. (2014). LSD Flashbacks – The Appearance
of New Visual Imagery Not Experienced During Initial Intoxication: Two Case Reports. Israeli
Journal of Psychiatry Related Science, 51(4), 307-309.
Lerner, A.G., Rudinski, D., Bor, O., & Goodman, C. (2014). Flashbacks and HPPD: A Clinical-
oriented Concise Review. Israeli Journal of Psychiatry Related Science, 51(4), 296-302.
Lerner, A.G., Goodman, C., Bor, O., & Lev Ran, S. (2014). Synthetic Cannabis Substances (SPS)
Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports. Israeli Journal
of Psychiatry Related Science, 51(4), 277-280.
Rudinski, D., Bor, O., Goodman, C. (2013). Flashbacks and HPPD: A Clinical-oriented Concise
Review. The Israel Journal of Psychiatry and Related Sciences, 51(4), 296-301.
Silver, H., Goodman, C., & Bilker, W.B. (2012). Impairment in associative memory in healthy
aging is distinct from that in other types of episodic memory. Psychiatry Research, 197(1-2),
135-139.
Lerner, A.G., Goodman, C., Rudinski, D., & Bleich, A. (2011). Benign and time-limited visual
disturbances (flashbacks) in recent abstinent high-potency heavy cannabis smokers: a case
series study. Israeli Journal of Psychiatry and Related Science, 48(1), 25-29.

7. 7
Silver, H., Goodman, C., Gur, R.C., Gur, R.E., & Bilker, W.B. (2011). 'Executive' functions and
normal aging: selective impairment in conditional exclusion compared to abstraction and
inhibition. Dementia and Geriatric Cognitive Disorders, 31(1), 53-62.
Finkel, B., Goodman, C., Melamed, Y., Kurs, R., & Bleich, A. (2010). Effect of Antiviral
Amantadine Treatment on Elderly Chronic Schizophrenia Patients. The Israel Medical
Association Journal, 12(9), 536-538.
Silver, H., Goodman, C., & Bilker, W.B. (2009). Age in High-Functioning Healthy Men Is
Associated with Nonlinear Decline in Some Executive' Functions in Late Middle Age. Dementia
and Geriatric Cognitive Disorders, 27, 292–300.
Finkel, B., Goodman, C., & Melamed, Y. (2009). Differences of Metabolic Side Effects of Typical
and Atypical Antipsychotic Treatment in Elderly Individuals with Long-term Schizophrenia. Hong
Kong Journal of Psychiatry, 19, 103-106.
Silver, H., Bilker, W., & Goodman, C. (2009). Impaired recognition of happy, sad and neutral
expressions in schizophrenia is emotion, but not valence, specific and context dependent.
Psychiatry Research, 169(2), 101-106.
Silver, H., & Goodman, C. (2008). Verbal as well as spatial working memory predicts visuospatial
processing in male schizophrenia patients. Schizophrenia Research, 101, 210-217.
Silver, H., Goodman, C., Bilker, W.B., Knoll, G., Gur, R., & Povar, G. (2007). Suboptimal
processing strategy and working-memory impairments predict abstraction deficit in
schizophrenia. Journal of Clinical and Experimental Neuropsychology, 29(8), 823-830.
Silver, H., & Goodman, C. (2007). Impairment in error monitoring predicts poor executive
function in schizophrenia patients. Schizophrenia Research, 94(1-3), 156-163.
Goodman, C., Finkel, B., Naser, M., Andreev, P., Segev, Y., Kurs, R., Melamed, Y., & Bleich, A.
(2007). Neurocognitive Deterioration in Elderly Chronic Schizophrenia Patients with and
without PTSD. Journal of Nervous and Mental Disease, 195(5), 415-420.
Silver, H., Goodman, C., Bilker, W.B., Gur, R.C., Isakov, V., Knoll, G., & Feldman, P. (2006).
Related Impaired error monitoring contributes to face recognition deficit in schizophrenia
patients. Schizophrenia Research, 85(1-3), 151-161.
Silver, H., Goodman, C., Isakov, V., Knoll, G., & Modai, I. (2005). A double-blind, cross-over
comparison of the effects of amantadine or placebo on visuomotor and cognitive function in
medicated schizophrenia patients. International Clinical Psychopharmacology, 20(6), 319-326.

8. 8
Silver, H., Knoll, G., Isakov, V., Goodman, C., & Finkelstein, Y. (2005). Blood DHEAS
concentrations correlate with cognitive function in chronic schizophrenia patients: a pilot study.
Journal of Psychiatric Research, 39(6), 569-575.
Goodman, C., Knoll, G., Isakov, V., & Silver, H. (2005). Insight Into Illness in Schizophrenia.
Comprehensive Psychiatry, 46(4), 284-290.
Goodman, C., Knoll, G., Isakov, V., & Silver, H. (2005). Negative attitude towards medication is
associated with working memory impairment in schizophrenia patients. International Clinical
Psychopharmacology, 20(2), 93-96.
Silver, H., Goodman, C., Knoll, G., Isakov, V., & Modai, I. (2005). Schizophrenia patients with a
history of severe violence differ in perception of emotions but not cognitive function from non
violent schizophrenia patients. Journal of Clinical Psychiatry, 66(3), 300-308.
Goodman, C., Knoll, G., Isakov, V., & Silver, H. (2005). Negative attitude towards medication is
associated with cognitive impairment in schizophrenia patients. Israel Journal of Psychiatry,
42(4), 23.
Goodman, C., Finkel, B., Naser, M., Andreev, P., Segev, Y., Zadkani, O., Melamed, Y., & Bleich, A.
(2005). Neurocognitive deterioration in Holocaust survivors and non-survivors with
schizophrenia. Israel Journal of Psychiatry,
42(4), 48-49.
Silver, H., Goodman, C., Knoll, G., & Isakov, V. (2004). Brief emotion training improves
recognition of facial emotions in chronic schizophrenia. A pilot study. Psychiatry Research,
128(2), 147-154.
Finkel, B., Andreev, P., Naser, M., Segev, Y., Goodman, C., Barak, Y., Melamed, Y., & Bleich, A.
(2004). No weight gain during two years of treatment with atypical and typical antipsychotics in
elderly schizophrenic patients. Israel Journal of Psychiatry, 41(1), 50.
Goodman, C., Knoll, G., Isakov, V., & Silver, H. (2005). Insight Into Illness in Schizophrenia. Israel
Journal of Psychiatry, 41(1), 51.
Silver, H., Goodman, C., Knoll, G., Isakov, V., & Modai, I. (2004). Perception Of Emotions And
Violence In Schizophrenia. Israel Journal of Psychiatry, 41(4), 20.
Goodman, C., Rodionov, V., Rosenstein, G.Z., & Sohmer, H. (2003). Analysis of Evoked and
Background EEG Activity in Young and Elderly Subjects. Journal of Basic and Clinical Physiology
and Pharmacology, 14(3), 265-299.

9. 9
Rodionov, V., Goodman, C., Fisher, L., Rosenstein, G.Z., & Sohmer, H. (2002). A New Technique
for the Analysis of Background and Evoked EEG Activity: Time and Amplitude Distributions of
the EEG Deflections. Clinical Neurophysiology, 113(9), 1373-1522.
Presentations
Goodman, C., Knoll, G., Isakov, V., & Silver, H. Negative attitude towards medication is
associated with cognitive impairment in schizophrenia patients. Presented at the Ninth Annual
Meeting of the Israel Society for Biological Psychiatry & The Fourth Meeting of the US-Israel
Forum for Academic Psychiatry; March 15-17, 2005 Hagoshrim, Israel.
Goodman, C., Finkel, B., Naser, M., Andreev, P., Segev, Y., Zadkani, O., Melamed, Y., & Bleich, A.
Neurocognitive deterioration in Holocaust survivors and non-survivors with schizophrenia.
Presented at the Ninth Annual Meeting of the Israel Society for Biological Psychiatry & The
Fourth Meeting of the US-Israel Forum for Academic Psychiatry; March 15-17, 2005 Hagoshrim,
Israel.
Goodman, C., Knoll, G., Isakov, V., & Silver, H. Insight Into Illness in Schizophrenia. Presented at
the Eighth Annual Meeting of the Israel Society for Biological Psychiatry & The Third Meeting of
the US-Israel Forum for Academic Psychiatry; March 16-18, 2004 Kfar Giladi, Israel.
Finkel, B., Andreev, P., Naser, M., Segev, Y., Goodman, C., Barak, Y., Melamed, Y., & Bleich, A.
No weight gain during two years of treatment with atypical and typical antipsychotics in elderly
schizophrenic patients. Presented at the Eighth Annual Meeting of the Israel Society for
Biological Psychiatry & The Third Meeting of the US-Israel Forum for Academic Psychiatry;
March 16-18, 2004 Kfar Giladi, Israel.
Silver, H., Goodman, C., Knoll, G., Isakov, V., & Modai, I. Perception Of Emotions And Violence
In Schizophrenia. Presented at the Eighth Annual Meeting of the Israel Society for Biological
Psychiatry & The Third Meeting of the US-Israel Forum for Academic Psychiatry; March 16-18,
2004 Kfar Giladi, Israel.
Goodman, C. Investigation of core neuropsychological impairments in schizophrenia.
Presented at the 11th Conference of the Israeli Psychiatric Association;
April 29 - May 1, 2003 - Haifa, Israel.
Goodman, C., Rodionov, V., Sohmer, H., & Rosenstein, G.Z. Technique for the Analysis of
Evoked and Background EEG Activity applied to Young and Elderly Subjects. Presented at the
Israeli Society for Clinical Neurophysiology Conference; September 6, 2001; Ramat Aviv, Israel.

10. 10
Reviewer for Scientific Journals
European Archives of Psychiatry and Clinical Neuroscience
International Journal of Medicine and Medical Sciences
International Clinical Psychopharmacology
International Journal of Psychiatry and Mental Health
Journal of Nervous and Mental Disease